Europe Diet Pills Market To Grow At A CAGR Of 2.6% By 2031

The diet pills demand in Europe will consistently rise at 2.6% CAGR between 2021 and 2031. As per Fact MR, overall sales in Europe will total US$ 669 Mn in 2021. Historically, sales of diet pills in Europe have been observed at 0.7% CAGR between 2016 and 2020.

Glucomannan diet pills demand is anticipated to grow from US$ 258.1 Mn in 2020 to around US$ 361.2 Mn by 2031, while sales of herbal supplements is expected to reach US$ 611.6 Mn in 2031 from a valuation of US$ 455.1 Mn in 2020.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗥𝗘𝗘 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=6494

Nowadays, an increasing number of people are focusing on including dietary supplements such as diet pills in their routine. This trend is making inroads in countries such as the U.K. and Germany on account of the prevalence of obesity and consequent focus on adopting a healthier lifestyle.

According to World Health Organization (WHO), in 2017 around 29% of geriatric population were categorized as obese in the U.K. Against this backdrop, focus on a healthy living is on the rise. Consequently the demand for fat blocker pills and demand for weight loss pills have gained tremendous traction in the country.

As per Fact MR, sales of diet suppressants are expected to rise at 3% CAGR in Germany. Increasing focus on health and wellness will remain the primary growth drivers. Thanks to rising awareness, self-medication has become immensely popular in Germany, consequently creating opportunities for sales of diet pills.

"Strategic partnerships remain highly sought-after among companies aiming at competitive advantage. As the focus on capacity expansion continues rising, an increasing number of market players will invest in merger and acquisitions, "said a Fact MR analyst.

Key Takeaways for Europe Diet Pills Market Research Report:

• Demand for prescription-based pills for weight loss will continue rising in the U.K. Fact MR predicts overall diet pill sales in the country to surpass US$ 193 Mn by 2031.
• Sales of diet pills in Germany will rise at 3% CAGR owing to rising concerns about health and wellness.
• By drug class, glucomannan segment accounted for over 39.5% of the Europe market in 2020.
• By drug type, herbal diet supplements sales totalled US$ 444.3 Mn in 2020 owing to increase in demand for organic product consumption.

Growth Drivers:

• Rising spending on dietary supplements and nutrition are driving demand for diet pills for appetite control.
• Expansion of distribution channels for diet pills will bolster sales opportunities in Europe.
• Rising adoption of drugs for weight loss and obesity-control will accelerate demand for weight loss pills in Europe.
• Increasing availability across e-commerce platforms will encourage diet pill sales in Europe.

Key Restraints:

• High cost of drug development is hindering demand for diet pills.
• Stringent regulations imposed by research and development of obesity related drugs will restrain market growth.
• Adoption of off-label drugs limits penetration of actual drugs which is restraining market growth.

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=RC&rep_id=6494

Competitive Landscape:

Key players are focusing on expansion in emerging countries and introducing features in their product lines. For instance,

• In September 2019, Currax™ Pharmaceuticals LLC declared acquisition of Nalpropion Pharmaceuticals, Inc. Currax has global rights to CONTRAVE, which is a leading prescription of weight loss brand medication.
• In June 2020, Holland, Barrett, and Deliveroo are partnering to deliver more than 200 products from 50 stores across the U.K.
• In September 2018, Nature's Way Products, LLC and Natural Products Canada introduced an investment agreement for investing in new companies which works in natural products sectors such as supplements and dietary ingredients.

Key players are operating in the market include

• GlaxoSmithKline plc.
• Cheplapharm Arzneimittel GmbH
• Holland & Barrett Retail Limited
• Cresent Pharma.
• Currax Pharmaceuticals LLC (OREXIGEN THERAPEUTICS IRELAND LTD)
• Himalaya Wellness (The Himalaya Drug Company)
• Nature's Way Products, LLC
• zeinpharma
• SimplySupplements
• Lindens Health + Nutrition

𝗚𝗲𝘁 𝗙𝘂𝗹𝗹 𝗔𝗰𝗰𝗲𝘀𝘀 𝗼𝗳 𝗖𝗼𝗺𝗽𝗹𝗲𝘁𝗲 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/checkout/6494

More Insights on the Global Europe Diet Pills Sales Outlook

Fact MR provides an unbiased analysis of the Europe diet pills demand outlook, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the Europe diet pills market with a detailed segmentation on the basis of:

Drug Class

• Lipase Inhibitors
• Choline
• Glucomannan
• Garcinia Cambogia
• Others

Drug Type

• Prescription Drugs
• OTC Drugs
• Herbal Supplements

Mechanism

• Metabolism Raising Diet Pills
• Fat Blocking Diet Pills
• Appetite Controlling Diet Pills
• Others

Distribution Channel

• Diet Pills Sold at Hospital Pharmacies
• Diet Pills Sold at Retail Pharmacies
• Diet Pills Sold at Clinics
• Online Sales of Diet Pills (e-Commerce)
• Stores
• Amazon
• Pharmacies
• Sales of Diet Pills by Drug Stores

𝗖𝗵𝗲𝗰𝗸 𝗼𝘂𝘁 𝗺𝗼𝗿𝗲 𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗯𝘆 𝗙𝗮𝗰𝘁.𝗠𝗥 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵: https://www.globenewswire.com/news-release/2022/10/03/2526452/0/en/Sales-of-Laparotomy-Sponges-Are-Projected-to-Reach-a-Market-Size-of-US-1-6-billion-By-2027-Radiopaque-Laparotomy-Sponges-Widely-Used-in-Thoracic-Surgical-Procedures-Report-Fact-MR.html

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.